Looking forward to
#ASV2023! Come hear how we applied our RNA platform to target a nonenveloped virus
#EVD68 (not as straightforward as enveloped viruses). See W16-9 (@DrNikkiWarner21 ) for the vaccine story and W16-1 (me) for the RNA-launched nanobody story. We applied an integrated approach using replicon RNA to develop the vaccine, use that to discover nanobodies, and then launch those from the same platform.